Mengis Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Mengis Capital Management, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $58.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$58.5M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 70,648 | $10.8M |
| JNJJOHNSON & JOHNSON | 40,968 | $10.0M |
| LLYELI LILLY & Co | 9,878 | $9.1M |
| PMPhilip Morris International Inc | 44,400 | $7.3M |
| MRKMerck & Co., Inc. | 48,922 | $5.9M |
| GEHCGE HealthCare Technologies Inc. | 45,907 | $3.3M |
| NVONovo Nordisk A/S | 70,364 | $2.6M |
| BMYBRISTOL MYERS SQUIBB CO | 40,858 | $2.5M |
| AMGNAMGEN INC | 6,047 | $2.1M |
| ABBVAbbVie Inc. | 9,217 | $2.0M |
| PFEPFIZER INC | 63,588 | $1.8M |
| VTRSViatris Inc | 35,192 | $475K |
| ABTABBOTT LABORATORIES | 4,181 | $429K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 500 | $223K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.